Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma

Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma

Abstract Lung squamous cell carcinoma (LUSC) possesses a poor prognosis even for stages I–III resected patients. Reliable prognostic biomarkers that can stratify and predict clinical outcomes for stage I–III resected LUSC patients are urgently needed. Based on gene expression of LUSC tissue samples...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qi-Fan Yang, Di Wu, Jian Wang, Li Ba, Chen Tian, Yu-Ting Liu, Yue Hu, Li Liu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/e3d3131177f044b8a16fa6a095441956
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares